1. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005;30(10):996-1002.
2. Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005;162(5):847-55.
3. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62(8):903-10.
4. Lipowski ZJ. Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom 1987;47(3-4):160-7.
5. Kroenke K. Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 2006;60(4):335-9.
6. Simon GE, Gureje O. Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry 1999;56(1):90-5.
7. Phillips KA, McElroy SL, Hudson JI, Pope HG, Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry 1995;56(suppl 4):41-51.
8. Tyrer S. Psychosomatic pain. Br J Psychiatry 2006;188:91-3.
9. Starcevic V. Somatoform disorders and DSM-V: conceptual and political issues in the debate. Psychosomatics 2006;47(4):277-81.
10. Hiller W, Rief W. Why DSM-III was right to introduce the concept of somatoform disorders. Psychosomatics 2005;46(2):105-8.
11. Bleichhardt G, Timmer B, Rief W. Cognitive-behavioural therapy for patients with multiple somatoform symptoms—a randomised controlled trial in tertiary care. J Psychosom Res 2004;56(4):449-54.
12. Smith GR, Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder. A randomized controlled study. N Engl J Med 1986;314(22):1407-13.
13. Lidbeck J. Group therapy for somatization disorders in general practice: effectiveness of a short cognitive-behavioural treatment model. Acta Psychiatr Scand 1997;96(1):14-24.
14. Guthrie E, Creed F, Dawson D, Tomenson B. A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. Br J Psychiatry 1993;163:315-21.
15. Allen LA, Woolfolk RL, Escobar JI, et al. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166(14):1512-8.
16. Muller T, Mannel M, Murck H, Rahlfs VW. Treatment of somatoform disorders with St. John’s wort: a randomized, double-blind and placebo-controlled trial. Psychosom Med 2004;66(4):538-47.
17. Kroenke K, Messina N, 3rd, Benattia I, et al. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. J Clin Psychiatry 2006;67(1):72-80.
18. Aragona M, Bancheri L, Perinelli D, et al. Randomized double-blind comparison of serotonergic (citalopram) versus noradrenergic (reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain 2005;9(1):33-8.
